Resources Practice resources Product Information, patient education materials, and other resources. Patient Information Patient information on Multiple Myeloma, Products, and patient resources like financial support and and copay cards. Search for: Recent Content Myeloma-bone marrow adipocyte axis in tumour survival and treatment response [Action required] Your RSS.app Trial has Expired – Mon Jun 21 2021 Top Myeloma Journal Articles for the Week of June 14, 2021 Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial MM_Hub: CONGRESS|#EHA2021|@ThierryFacon, Lille University Hospital, presented poster on Phase3 IKEMA trial. It was identified that addition of Isatuximab to carfilzomib & dexamethasone improved PFS & quality of response in elderly pts, with a manageable safety profile #mmsm #myeloma VincentRK: The 12th Annual International Myeloma Working Group (IMWG) Summit starts next week. ~100 myeloma experts will participate virtually on new treatment guidelines & research projects. @IMFmyeloma @BrianDurieMD Dr. Munshi and Dr. Kumar will be honored. @DanaFarber @MayoClinic MM_Hub: CONGRESS|#EHA2021|@nickbolli, Universita Degli Studi di Milano emphasized upon genotyping potential to diagnose MGUS/SMM, to identify progression determinants, to provide better classification& prognostication of MM. More research is needed for clinical translation #mmsm #myeloma MM_Hub: CONGRESS|#EHA2021| Paula Rodriguez- Otero, discussed currently cellular therapies for MM and highlighted future treatment possibilities #mmsm #myeloma @ClinicaNavarra MM_Hub: CONGRESS|#EHA2021|@IreneGhobrial, @Mohty_EBMT discussed in an interactive session about factors, challenges in selecting therapy, optimization & pt management after 1st relapse in RRMM #mmsm #myeloma MM_Hub: CONGRESS|#EHA2021|@JoshuaRichterMD & Fredrik Schjesvold discussed clinical challenges for late stage RRMM pts. Implication of 5 possible treatment options was also debated #mmsm #myeloma
